Linda Feagins

Associate Professor

The University of Texas at Austin Dell Medical School

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Linda Feagins serves as an Associate Professor at the University of Texas at Austin Dell Medical School in the United States. Her research primarily focuses on inflammatory bowel diseases, colorectal cancer, and the role of diet in disease management. Recent publications include significant contributions to understanding biosimilars, cancer signaling pathways, and patient healthcare utilization in advanced liver disease.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (3)

Sara Di Rienzi

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Joseph Garcia

Professor of Medicine

Columbia University

UNITED STATES

View details

Arianne L. Theiss

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Linda Feagins

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Overview of Biosimilars in Inflammatory Bowel Diseases

Acss2/HIF-2 signaling facilitates colon cancer growth and metastasis

Delayed Diagnostic Paracentesis Is Associated with Increased Preventable Healthcare Utilization in Disadvantaged Patient Populations with Advanced Liver Disease and Elevated INR

Human intestinal organoids from Cronkhite-Canada syndrome patients reveal link between serotonin and proliferation

Clip closure to prevent adverse events after EMR of proximal large nonpedunculated colorectal polyps: meta-analysis of individual patient data from randomized controlled trials

Diet in the Pathogenesis and Management of Crohn's Disease

Timing of Resumption of Anticoagulation After Polypectomy and Frequency of Post-procedural Complications: A Post-hoc Analysis

Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy

Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn’s Disease

Dining with Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD

Collaborators (3)

Sara Di Rienzi

Joseph Garcia

Arianne L. Theiss

Make your next move.